Isodiol International Inc. Signs Letter of Intent to Acquire 100% of Green Island Naturals

0 Comments 2 view(s)

VANCOUVER, British Columbia, Jan. 12, 2018 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has signed a Letter of Intent to acquire 100% of the CBD assets of Green Island Naturals.

Green Island Naturals is a formulator, marketer and seller of a proprietary line of hemp extract products that are distributed in retail and online channels in Canada.  By combining science with a deep understanding of traditional plant based medicines, Green Island Naturals produces innovative products designed to improve and diversify treatment options for the consumers.  In 2017 revenues exceed over $2,000,000 and the Company anticipate this to grow exponentially in 2018 with the support of Isodiol’s family of brands.

“Isodiol and the Green Island Naturals brand share a mutual goal of providing consumers with high-quality Cannabinoid products that promote both physical and mental well-being, making this partnership an easy decision,” said Marcos Agramont, CEO of Isodiol. “This acquisition also allows us to diversify our product offerings, expand our distribution partners, and remain leaders in product innovation. Isodiol is growing at a rapid pace; in addition to the increase of revenue this partnership will bring, it has also enabled …

Full story available on Benzinga.com